Skip to main content
CTNM logo

CTNM · Contineum Therapeutics, Inc. · Proposed Sales

Track CTNM — free
$8.46 +1.02 (+13.71%) At close · Oct 20
Market Cap
$318.27M
Shares
37.62M
Volume · Oct 20 2.2M Avg daily vol (3M) 780.14K

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-10-01 Daniel Lorrain 4,170
2026-09-08 CARMINE STENGONE 2,500
2026-09-01 Daniel Lorrain 9,520
2026-08-03 CARMINE STENGONE 2,500
2026-08-03 Daniel Lorrain 9,520
2026-07-08 CARMINE STENGONE 2,500
2026-07-01 Daniel Lorrain 9,520
2026-06-30 CARMINE STENGONE 10,000
2026-06-30 TIMOTHY WATKINS 10,833
2026-06-30 Daniel Lorrain 28,826
2026-06-01 DANIEL LORRAIN 4,170
2026-05-01 DANIEL LORRAIN 4,170
2026-04-06 DANIEL LORRAIN 914
2026-02-11 DANIEL LORRAIN 16,050
2026-02-11 CARMINE STENGONE 7,500
2026-02-03 DANIEL LORRAIN 4,170
2026-01-05 DANIEL LORRAIN 4,170
2025-12-29 TIMOTHY WATKINS 10,833
2025-12-23 DANIEL LORRAIN 4,170
2024-11-18 DANIEL LORRAIN 26,370
Showing 1–20 of 20 filings
Key facts CIK 1855175 CUSIP 21217B100 13F (30d) 7 filings 7 filers Visit website Investor relations